|
Apr 10
|
Post-Hoc Analysis of the OPTIMIZE Study Supporting XPHOZAH® (tenapanor) to be Presented at the National Kidney Foundation Spring Clinical Meetings
|
|
Mar 13
|
Ardelyx Announces the First Recipients of Derek Forfang Patient Advocate Award
|
|
Mar 10
|
High Growth Tech Stocks In The US With Promising Potential
|
|
Feb 21
|
Ardelyx Inc (ARDX) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic Challenges
|
|
Feb 21
|
Q4 2024 Ardelyx Inc Earnings Call
|
|
Feb 20
|
Ardelyx (ARDX) Reports Q4 Earnings: What Key Metrics Have to Say
|
|
Feb 20
|
Ardelyx (ARDX) Meets Q4 Earnings Estimates
|
|
Feb 20
|
Ardelyx: Q4 Earnings Snapshot
|
|
Feb 20
|
Ardelyx Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
|
|
Feb 19
|
Ardelyx to Present at the TD Cowen 45th Annual Health Care Conference
|
|
Feb 17
|
BioCryst Pharmaceuticals (BCRX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
|
|
Dec 30
|
Why Ardelyx (ARDX) Is One of the Best Biotech Penny Stocks to Invest in Now?
|
|
Dec 30
|
Exploring 3 High Growth Tech Stocks in the United States
|